• Nektar pulls NDA for pain drug after unanimous AdComm rejection

    13 days ago - By Fierce Biotech

    Nektar Therapeutics has withdrawn the new drug application for its opioid oxycodegol after an advisory committee unanimously recommended against approval. The 27-0 vote against approval followed questioning of Nektar's decision to run one pivotal trial and the extent to which it assessed the risk of abuse.
    Read more ...